Call for Papers

Translational Research on Stem Cells for Parkinson's Disease

Guest Editor:

Marcel Daadi, Texas Biomedical Research Institute

This summer, two more patients with Parkinson's disease were successfully transplanted with neural stem cells derived from human parthenogenetic stem cells at the Royal Melbourne Hospital, Australia. They are in the second cohort of a dose escalation safety and preliminary efficacy study of a Phase I clinical trial. The understandable excitement this has generated is tempered with worldwide concern for the safe translation of stem cell research to an effective treatment for this terrible disease and other neurological conditions.

Clinicians and biomedical researchers are hereby invited to submit to Stem Cells and Development on the responsible advancement of cell therapy for Parkinson's Disease by contributing an Original Research Report, a commentary piece, or a select few reviews on this topic.

Submissions addressing the following are encouraged:

  • What is the optimal cell type and level of differentiation for transplantation?
  • How will functional cell integration be achieved?
  • What is the necessary weight of supporting preclinical evidence to justify translation to clinical application?
  • What are the key safety issues in brain stem cell transplant and how should they be addressed?

Please submit your papers online to our online manuscript submission and peer-review system.

Benefits of publishing in the journal:

  • Rapid, rigorous peer-review
  • Open Access options available
  • Maximum exposure: accessible in 170 countries worldwide
  • Indexed in key indexing services
  • New end-to-end Author Benefits Program

Learn More about this journal

Deadline for Manuscript Submission:
December 15, 2017


Questions or relevant proposals,
please contact:

Guest Editor Marcel Daadi or
Editor-in-Chief Graham Parker